Stock Ideas
Stocks
Funds
Screener
Sectors
Watchlists

Latest Lynx1 Capital Management LP Stock Portfolio

$388Million– No. of Holdings #16

Lynx1 Capital Management LP Performance:
2024 Q1: 44.92%YTD: 44.92%2023: 72.82%

Performance for 2024 Q1 is 44.92%, and YTD is 44.92%, and 2023 is 72.82%.

About Lynx1 Capital Management LP and 13F Hedge Fund Stock Holdings

Lynx1 Capital Management LP is a hedge fund based in SAN JUAN, PR. On 03-Mar-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $136.4 Millions. In it's latest 13F Holdings report, Lynx1 Capital Management LP reported an equity portfolio of $388.2 Millions as of 31 Mar, 2024.

The top stock holdings of Lynx1 Capital Management LP are IBIO. The fund has invested 0.6% of it's portfolio in IBIO and NA% of portfolio in NA.

Lynx1 Capital Management LP opened new stock positions in IBIO (IBIO).
Lynx1 Capital Management LP Equity Portfolio Value
Last Reported on: 15 May, 2024

Lynx1 Capital Management LP Annual Return Estimates Vs S&P 500

Our best estimate is that Lynx1 Capital Management LP made a return of 44.92% in the last quarter. In trailing 12 months, it's portfolio return was 137.98%.

New Buys

Ticker$ Bought
ibio2,436,000
centessa pharmaceuticals plc196,620

New stocks bought by Lynx1 Capital Management LP

Additions

Ticker% Inc.
passage bio inc1,178
silence therapeutics plc123
gh research plc80.06
merus n v32.93
stoke therapeutics inc25.02
c4 therapeutics inc15.96
nektar therapeutics7.24

Additions to existing portfolio by Lynx1 Capital Management LP

Reductions

Ticker% Reduced
alpine immune sciences inc-40.92
autolus therapeutics plc-25.2
pieris pharmaceuticals inc-10.2
cabaletta bio inc-1.3
bionomics limited-1.19
kinnate biopharma inc-0.8

Lynx1 Capital Management LP reduced stake in above stock

Sold off

Ticker$ Sold
theseus pharmaceuticals inc-2,844,780

Lynx1 Capital Management LP got rid off the above stocks

Sector Distribution

Lynx1 Capital Management LP has about 85.5% of it's holdings in Healthcare sector.

Sector%
Healthcare85.5
Others14.5

Market Cap. Distribution

Lynx1 Capital Management LP has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.

Category%
SMALL-CAP40.8
MID-CAP40.5
UNALLOCATED14.5
MICRO-CAP3.5

Stocks belong to which Index?

About 45% of the stocks held by Lynx1 Capital Management LP either belong to S&P 500 or RUSSELL 2000 index.

Index%
Others55
RUSSELL 200045
Top 5 Winners (%)%
IBIO
ibio
244.1 %
STOK
stoke therapeutics inc
156.6 %
ALPN
alpine immune sciences inc
90.0 %
NKTR
nektar therapeutics
62.5 %
MRUS
merus n v
42.7 %
Top 5 Winners ($)$
ALPN
alpine immune sciences inc
65.4 M
STOK
stoke therapeutics inc
30.5 M
MRUS
merus n v
20.3 M
TCRX
tscan therapeutics inc
11.0 M
CCCC
c4 therapeutics inc
8.0 M
Top 5 Losers (%)%
CABA
cabaletta bio inc
-24.6 %
Top 5 Losers ($)$
CABA
cabaletta bio inc
-11.8 M

Lynx1 Capital Management LP Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Lynx1 Capital Management LP

Lynx1 Capital Management LP has 16 stocks in it's portfolio. About 96.8% of the portfolio is in top 10 stocks. CABA proved to be the most loss making stock for the portfolio. ALPN was the most profitable stock for Lynx1 Capital Management LP last quarter.

Last Reported on: 15 May, 2024
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions